FENTANYL CITRATE INJECTION, USP

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: 67058abf7e643c92
Drug Approval Canada Name: FENTANYL CITRATE INJECTION, USP
Product Name: FENTANYL CITRATE INJECTION, USP
Status: Marketed
Status Date: 2021-06-18
Original Market Date: 2021-06-18
Din: 02501554
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Epidural , Intramuscular , Intravenous
Schedule: Narcotic (CDSA I)
Ahfs: 28:08.08
Atc Original: N01AH01 FENTANYL
Atc Name: n 01 ah 01
Aig Number: 0123302002
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

FENTANYL (FENTANYL CITRATE)

50 MCG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

67058abf7e643c92

Type

Standard